XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2

Consolidated Schedule of Investments (Unaudited)

6 Months Ended

Jun. 30, 2023

Notes to Financial Statements

Schedule of Investments [Text Block]

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)				Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Non-Affiliate Investments — 201.1% (8)
Non-Affiliate Debt Investments — 192.3% (8)
Non-Affiliate Debt Investments — Life Science — 82.9% (8)
Avalo Therapeutics, Inc. (2)(5)(12)		Biotechnology		Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025		$	2,055			$	2,011			$	1,938
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025			2,028				1,982				1,910
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025			1,014				991				955
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		February 1, 2025			2,028				1,980				1,907
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		February 1, 2025			2,028				1,980				1,907
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		April 1, 2025			1,014				987				951
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				3.00	%		April 1, 2025			1,014				987				951
Castle Creek Biosciences, Inc. (2)(12)		Biotechnology		Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,899				4,899
				Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,971				4,971
				Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			3,000				2,982				2,982
				Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,971				4,971
				Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,971				4,971
				Term Loan			13.13	%		Prime			4.88	%			9.55	%			13.50	%			5.50	%		May 1, 2026			3,000				2,982				2,982
Emalex Biosciences, Inc. (2)(12)		Biotechnology		Term Loan			12.97	%		Prime			4.72	%			9.75	%			-				5.00	%		June 1, 2024			1,979				1,968				1,968
				Term Loan			12.97	%		Prime			4.72	%			9.75	%			-				5.00	%		June 1, 2024			1,979				1,969				1,969
				Term Loan			12.97	%		Prime			4.72	%			9.75	%			-				5.00	%		November 1, 2025			5,000				4,936				4,936
				Term Loan			12.97	%		Prime			4.72	%			9.75	%			-				5.00	%		May 1, 2026			5,000				4,930				4,930
Evelo Biosciences, Inc. (2)(5)(12)		Biotechnology		Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			10,000				9,887				9,887
				Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			15,000				14,830				14,830
				Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			6,000				5,932				5,932
				Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			6,000				5,932				5,932
				Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			4,000				3,955				3,955
				Term Loan			12.50	%		Prime			4.25	%			11.00	%			-				4.25	%		January 1, 2028			4,000				3,955				3,955
Greenlight Biosciences, Inc. (2)(5)(12)		Biotechnology		Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				3.00	%		July 1, 2025			4,000				3,886				3,859
				Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				3.00	%		July 1, 2025			2,000				1,944				1,931
IMV Inc. (5)(12)(13)(15)		Biotechnology		Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				5.00	%		July 1, 2025			5,035				4,988				2,814
				Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				5.00	%		July 1, 2025			2,500				2,476				1,397
				Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				5.00	%		January 1, 2026			5,000				4,953				2,795
				Term Loan			14.00	%		Prime			5.75	%			9.00	%			-				5.00	%		January 1, 2026			5,000				4,953				2,794
KSQ Therapeutics, Inc. (2)(12)		Biotechnology		Term Loan			13.00	%		Prime			4.75	%			8.50	%			-				5.50	%		May 1, 2027			6,250				6,188				6,188
				Term Loan			13.00	%		Prime			4.75	%			8.50	%			-				5.50	%		May 1, 2027			6,250				6,188				6,188
Native Microbials, Inc (2)(12)		Biotechnology		Term Loan			13.50	%		Prime			5.25	%			8.50	%			-				5.00	%		November 1, 2026			3,750				3,711				3,711
				Term Loan			13.50	%		Prime			5.25	%			8.50	%			-				5.00	%		November 1, 2026			2,500				2,475				2,475
PDS Biotechnology Corporation (2)(5)(12)		Biotechnology		Term Loan			14.00	%		Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			10,000				9,727				9,727
				Term Loan			14.00	%		Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			3,750				3,707				3,707
				Term Loan			14.00	%		Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			3,750				3,707				3,707
Provivi, Inc. (2)(12)		Biotechnology		Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			4,667				4,605				4,605
				Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			4,667				4,605				4,605
				Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,289				2,289
				Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,289				2,289
				Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,284				2,284
				Term Loan			13.61	%		Prime			5.36	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,284				2,284

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)				Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Stealth Biotherapeutics Inc. (2)(12)		Biotechnology		Term Loan			13.75	%		Prime			5.50	%			8.75	%			-				6.00	%		October 1, 2025			4,750				4,680				4,680
				Term Loan			13.75	%		Prime			5.50	%			8.75	%			-				6.00	%		October 1, 2025			2,375				2,338				2,338
Aerobiotix, LLC (2)(12)		Medical Device		Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				6.00	%		April 1, 2026			2,500				2,471				2,358
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				6.00	%		April 1, 2026			2,500				2,471				2,358
Ceribell, Inc. (2)(12)		Medical Device		Term Loan			11.75	%		Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			5,000				4,981				4,981
				Term Loan			11.75	%		Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			5,000				4,981				4,981
				Term Loan			11.75	%		Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			2,500				2,485				2,485
				Term Loan			11.75	%		Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			2,500				2,485				2,485
Cognoa, Inc. (2)(12)		Medical Device		Term Loan			13.75	%		Prime			5.50	%			8.75	%			-				6.00	%		August 1, 2026			5,000				4,948				4,948
				Term Loan			13.75	%		Prime			5.50	%			8.75	%			-				6.00	%		August 1, 2026			2,500				2,474				2,474
Conventus Orthopaedics, Inc. (2)(12)		Medical Device		Term Loan			13.07	%		Prime			4.82	%			9.25	%			-				10.36	%		July 1, 2025			3,960				3,910				3,910
				Term Loan			13.07	%		Prime			4.82	%			9.25	%			-				10.36	%		July 1, 2025			3,960				3,910				3,910
CSA Medical, Inc. (2)(12)		Medical Device		Term Loan			13.34	%		Prime			5.09	%			10.00	%			-				5.00	%		January 1, 2024			875				867				867
				Term Loan			13.34	%		Prime			5.09	%			10.00	%			-				5.00	%		January 1, 2024			58				58				58
				Term Loan			13.34	%		Prime			5.09	%			10.00	%			-				5.00	%		March 1, 2024			1,200				1,191				1,191
InfoBionic, Inc. (2)(12)		Medical Device		Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				4.00	%		October 1, 2024			2,771				2,724				2,724
				Term Loan			14.50	%		Prime			6.25	%			9.50	%			-				4.00	%		June 1, 2025			1,000				979				979
Magnolia Medical Technologies, Inc. (2)(12)		Medical Device		Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,953				4,953
				Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,953				4,953
				Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,948				4,948
				Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,949				4,949
				Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		January 1, 2027			5,000				4,927				4,927
				Term Loan			13.25	%		Prime			5.00	%			9.75	%			-				4.00	%		January 1, 2027			5,000				4,927				4,927
Robin Healthcare, Inc. (2)(12)		Medical Device		Term Loan			13.75	%		Prime			5.50	%			10.25	%			-				4.00	%		November 1, 2026			3,500				3,417				3,417
				Term Loan			13.75	%		Prime			5.50	%			10.25	%			-				4.00	%		November 1, 2026			3,500				3,467				3,467
Scientia Vascular, Inc. (2)(12)		Medical Device		Term Loan			13.00	%		Prime			4.75	%			8.50	%			-				5.00	%		January 1, 2027			3,750				3,659				3,659
				Term Loan			13.00	%		Prime			4.75	%			8.50	%			-				5.00	%		January 1, 2027			3,750				3,714				3,714
				Term Loan			13.50	%		Prime			5.25	%			9.00	%			-				5.00	%		March 1, 2027			5,000				4,928				4,928
Sonex Health, Inc. (2)(12)		Medical Device		Term Loan			14.75	%		Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,481				2,481
				Term Loan			14.75	%		Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,481				2,481
				Term Loan			14.75	%		Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,481				2,481
				Term Loan			14.75	%		Prime			6.50	%			9.75	%			-				8.00	%		April 1, 2026			2,500				2,463				2,463
				Term Loan			14.75	%		Prime			6.50	%			9.75	%			-				8.00	%		May 1, 2026			2,500				2,462				2,462
Spineology, Inc. (2)(12)		Medical Device		Term Loan			15.25	%		Prime			7.00	%			10.25	%			-				1.00	%		October 1, 2025			5,000				4,972				4,972
				Term Loan			15.25	%		Prime			7.00	%			10.25	%			-				1.00	%		April 1, 2026			2,500				2,485				2,485

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Swift Health Systems Inc. (2)(12)		Medical Device		Term Loan			13.50	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,460				3,460
				Term Loan			13.50	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,460				3,460
				Term Loan			13.50	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,450				3,450
				Term Loan			13.50	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,450				3,450
Total Non-Affiliate Debt Investments — Life Science																																		302,687				294,452
Non-Affiliate Debt Investments — Sustainability — 23.4% (8)
Aerofarms, Inc. (12)		Other Sustainability		Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		April 1, 2026			3,750				3,710				3,585
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		April 1, 2026			3,750				3,710				3,585
Nexii Building Solutions, Inc. (2)(12)(15)		Other Sustainability		Term Loan			15.25	%	Prime			7.00	%			10.25	%			-				2.50	%		August 27, 2025			7,500				7,395				7,024
				Term Loan			15.25	%	Prime			7.00	%			10.25	%			-				2.50	%		August 27, 2025			7,500				7,395				7,024
				Term Loan			15.25	%	Prime			7.00	%			10.25	%			-				2.50	%		August 27, 2025			7,500				7,395				7,024
				Term Loan			15.25	%	Prime			7.00	%			10.25	%			-				2.50	%		June 8, 2026			5,000				4,922				4,675
				Term Loan			15.25	%	Prime			7.00	%			10.25	%			-				2.50	%		June 8, 2026			5,000				4,922				4,675
				Term Loan			15.25	% (11)	Prime			7.00	%			10.25	%			-				-			September 30, 2023			680				680				646
				Term Loan			15.25	% (11)	Prime			7.00	%			10.25	%			-				-			September 30, 2023			542				542				515
Soli Organic, Inc. (2)(12)		Other Sustainability		Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.75	%		April 1, 2026			5,000				4,942				4,942
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.75	%		April 1, 2026			2,500				2,471				2,471
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.75	%		May 1, 2026			5,000				4,940				4,940
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.75	%		May 1, 2026			2,500				2,470				2,470
				Term Loan			13.75	%	Prime			5.50	%			11.75	%			-				2.75	%		December 1, 2026			5,000				4,917				4,917
				Term Loan			13.75	%	Prime			5.50	%			11.75	%			-				2.75	%		December 1, 2026			2,500				2,458				2,458
Temperpack Technologies, Inc. (2)(12)		Other Sustainability		Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.50	%		June 1, 2026			3,750				3,709				3,709
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.50	%		June 1, 2026			3,750				3,723				3,723
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2026			7,500				7,436				7,436
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2026			3,750				3,718				3,718
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2026			3,750				3,718				3,718
Total Non-Affiliate Debt Investments — Sustainability																																		85,173				83,255
Non-Affiliate Debt Investments — Technology — 75.9% (8)
Axiom Space, Inc. (2)(12)		Communications		Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,462				7,462
				Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,462				7,462
				Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,462				7,462
Better Place Forests Co. (12)(13)		Consumer-related Technologies		Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				1.85	%		July 1, 2025			5,104				5,056				3,426
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				1.85	%		October 1, 2025			2,500				2,474				1,677
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				100.00	%		September 30, 2023			150				150				102
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				100.00	%		September 30, 2023			250				250				169
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				100.00	%		September 30, 2023			250				250				169
CAMP NYC, Inc. (2)(12)		Consumer-related Technologies		Term Loan			15.50	%	Prime			7.25	%			10.50	%			-				3.00	%		May 1, 2026			3,500				3,467				3,467
Clara Foods Co. (2)(12)		Consumer-related Technologies		Term Loan			14.00	%	Prime			5.75	%			9.00	%			-				5.50	%		August 1, 2025			2,083				2,069				2,069
				Term Loan			14.00	%	Prime			5.75	%			9.00	%			-				5.50	%		August 1, 2025			2,083				2,069				2,069

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Divergent Technologies, Inc. (2)(12)		Consumer-related Technologies		Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,602				3,602
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,240				1,240
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,720				3,720
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,240				1,240
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,720				3,720
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,240				1,240
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		January 1, 2028			3,750				3,705				3,705
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		January 1, 2028			3,750				3,700				3,700
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		April 1, 2028			3,750				3,705				3,705
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2028			3,750				3,698				3,698
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2028			3,750				3,698				3,698
				Term Loan (14)			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2028			1,250				1,250				1,250
				Term Loan (14)			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2028			1,250				1,250				1,250
Havenly, Inc. (2)(12)		Consumer-related Technologies		Term Loan			13.25	%	Prime			5.00	%			5.00	%			-				4.00	%		March 1, 2027			2,000				1,250				1,250
				Term Loan			13.25	%	Prime			5.00	%			5.00	%			-				4.00	%		March 1, 2027			3,000				1,875				1,875
				Term Loan			11.75	%	Prime			3.50	%			10.50	%			-				7.78	%		February 1, 2028			2,813				2,813				2,813
				Term Loan			11.75	%	Prime			3.50	%			10.50	%			-				7.78	%		February 1, 2028			2,813				2,813				2,813
Lyrical Foods, Inc. (2)(12)		Consumer-related Technologies		Term Loan			10.75	%	Prime			2.50	%			8.00	%			-				-			September 1, 2027			2,598				2,589				2,330
MyForest Foods Co. (2)(12)		Consumer-related Technologies		Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		October 1, 2025			4,667				4,635				4,635
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		October 1, 2025			2,333				2,317				2,317
NextCar Holding Company, Inc. (2)(12)		Consumer-related Technologies		Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			5,352				5,304				4,630
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			2,141				2,124				1,854
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			2,676				2,658				2,320
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			3,211				3,189				2,784
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			2,676				2,644				2,308
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			2,676				2,644				2,308
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			5,351				5,287				4,614
				Term Loan			14.00	% (11)	Prime			5.75	%			9.00	%			-				5.25	%		October 31, 2023			2,676				2,642				2,306
Optoro, Inc. (2)(12)		Consumer-related Technologies		Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		August 1, 2027			2,500				2,400				2,400
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		July 1, 2028			1,875				1,779				1,779
Primary Kids, Inc. (2)(12)		Consumer-related Technologies		Term Loan			15.50	%	Prime			7.25	%			10.50	%			-				3.00	%		March 1, 2025			2,000				1,980				1,980
				Term Loan			15.50	%	Prime			7.25	%			10.50	%			-				3.00	%		March 1, 2025			2,000				1,980				1,980
				Term Loan			15.50	%	Prime			7.25	%			10.50	%			-				3.00	%		September 1, 2025			2,600				2,573				2,573
Unagi, Inc. (2)(12)		Consumer-related Technologies		Term Loan			16.00	% (11)	Prime			7.75	%			11.00	%			-				-			May 1, 2027			1,108				1,086				868
				Term Loan			16.00	% (11)	Prime			7.75	%			11.00	%			-				-			May 1, 2027			554				543				434
				Term Loan			16.00	% (11)	Prime			7.75	%			11.00	%			-				-			May 1, 2027			554				543				434
Liqid, Inc. (2)(12)		Networking		Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			2,333				2,300				2,300
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			2,333				2,300				2,300
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,167				1,149				1,149
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,167				1,149				1,149
				Term Loan			14.50	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,167				1,129				1,129
BriteCore Holdings, Inc. (2)(12)		Software		Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				5.00	%		March 1, 2026			2,500				2,489				2,489
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				5.00	%		March 1, 2026			2,500				2,489				2,489
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		March 1, 2027			2,500				2,469				2,469
				Term Loan			15.00	%	Prime			6.75	%			10.00	%			-				3.00	%		March 1, 2027			2,500				2,469				2,469

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Dropoff, Inc. (2)(12)		Software		Term Loan			14.75	%	Prime			6.50	%			9.75	%			-				3.50	%		April 1, 2026			6,500				6,370				6,370
				Term Loan			14.75	%	Prime			6.50	%			9.75	%			-				3.50	%		April 1, 2026			6,000				5,880				5,880
				Term Loan			14.75	%	Prime			6.50	%			9.75	%			-				3.50	%		August 1, 2026			2,500				2,447				2,447
Engage3, LLC (2)(12)		Software		Term Loan			14.50	%	Prime			6.25	%			9.75	%			-				4.50	%		July 1, 2027			3,750				3,723				3,723
				Term Loan			14.50	%	Prime			6.25	%			9.75	%			-				4.50	%		July 1, 2027			3,750				3,723				3,723
Kodiak Robotics, Inc. (2)(12)		Software		Term Loan			13.75	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			10,000				9,860				9,860
				Term Loan			13.75	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			10,000				9,860				9,860
				Term Loan			13.75	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			5,000				4,930				4,930
				Term Loan			13.75	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			5,000				4,930				4,930
Lemongrass Holdings, Inc. (2)(12)		Software		Term Loan			14.75	%	Prime			6.50	%			9.75	%			-				2.50	%		March 1, 2026			5,000				4,959				4,959
				Term Loan			14.75	%	Prime			6.50	%			9.75	%			-				2.50	%		March 1, 2026			2,500				2,480				2,480
Lytics, Inc. (2)(12)		Software		Term Loan			14.25	%	Prime			6.00	%			12.25	%			-				3.00	%		November 1, 2026			2,500				2,414				2,414
				Term Loan			14.25	%	Prime			6.00	%			12.25	%			-				3.00	%		December 1, 2026			1,250				1,234				1,234
				Term Loan			14.25	%	Prime			6.00	%			12.25	%			-				3.00	%		April 1, 2027			1,000				985				985
Noodle Partners, Inc. (2)(12)		Software		Term Loan			13.25	%	Prime			5.00	%			12.00	%			-				3.00	%		March 1, 2027			10,000				9,741				9,741
				Term Loan			13.25	%	Prime			5.00	%			12.00	%			-				3.00	%		March 1, 2027			5,000				4,932				4,932
				Term Loan			13.25	%	Prime			5.00	%			12.00	%			-				3.00	%		March 1, 2027			5,000				4,933				4,933
Reputation Institute, Inc. (2)(12)		Software		Term Loan			15.50	%	Prime			7.25	%			10.50	%			-				3.00	%		August 1, 2025			4,333				4,278				4,278
Slingshot Aerospace, Inc. (2)(12)		Software		Term Loan			14.00	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,946				4,946
				Term Loan			14.00	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,946				4,946
				Term Loan			14.00	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,882				4,882
				Term Loan			14.00	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,946				4,946
Supply Network Visibility Holdings LLC (2)(12)		Software		Term Loan			12.50	%	Prime			4.25	%			12.00	%			-				2.50	%		June 1, 2028			2,500				2,456				2,456
				Term Loan			12.50	%	Prime			4.25	%			12.00	%			-				2.50	%		June 1, 2028			3,500				3,488				3,488
				Term Loan			12.50	%	Prime			4.25	%			12.00	%			-				2.50	%		June 1, 2028			2,500				2,491				2,491
				Term Loan			12.50	%	Prime			4.25	%			12.00	%			-				2.50	%		June 1, 2028			1,500				1,495				1,495
Viken Detection Corporation (2)(12)		Software		Term Loan			12.25	%	Prime			4.00	%			11.75	%			-				3.50	%		June 1, 2027			5,000				4,762				4,762
				Term Loan			12.25	%	Prime			4.00	%			11.75	%			-				3.50	%		June 1, 2027			2,500				2,461				2,461
				Term Loan			12.25	%	Prime			4.00	%			11.75	%			-				3.50	%		June 1, 2027			2,500				2,461				2,461
Total Non-Affiliate Debt Investments — Technology																																		276,563				269,863
Non-Affiliate Debt Investments — Healthcare information and services — 10.1% (8)
Hound Labs inc. (2) (12)		Diagnostics		Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			2,500				2,478				2,478
				Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			2,500				2,478				2,478
				Term Loan			14.25	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			5,000				4,957				4,957
BrightInsight, Inc. (2)(12)		Software		Term Loan			13.75	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			7,000				6,670				6,670
				Term Loan			13.75	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			3,500				3,455				3,455
				Term Loan			13.75	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			3,500				3,455				3,455
				Term Loan			13.75	%	Prime			5.50	%			9.50	%			-				3.00	%		April 1, 2028			2,750				2,706				2,706
SafelyYou, Inc. (2)(12)		Software		Term Loan			11.50	%	Prime			3.25	%			11.00	%			-				5.00	%		June 1, 2027			5,000				4,635				4,635
				Term Loan			11.50	%	Prime			3.25	%			11.00	%			-				5.00	%		June 1, 2027			5,000				4,905				4,905
Total Non-Affiliate Debt Investments — Healthcare information and services																																		35,739				35,739
Total Non- Affiliate Debt Investments																																		700,162				683,309

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

										Cost of				Fair
Portfolio Company (1)(3)		Sector		Type of Investment (7)		Number of Shares				Investments (6)(9)				Value (9)
Non-Affiliate Warrant Investments — 7.2% (8)
Non-Affiliate Warrants — Life Science — 1.8% (8)
Avalo Therapeutics, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			26,444				311				—
Castle Creek Biosciences, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			7,404				212				338
Corvium, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			661,956				53				—
Emalex Biosciences, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			110,402				175				264
Evelo Biosciences, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			23,196				126				—
Greenlight Biosciences, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			47,452				366				—
Imunon, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			19,671				66				—
IMV Inc. (2)(5)(12)(15)		Biotechnology		Common Stock Warrant			39,774				67				—
KSQ Therapeutics, Inc. (2) (12)		Biotechnology		Preferred Stock Warrant			48,076				50				58
Mustang Bio, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			16,611				146				—
Native Microbials, Inc (2)(12)		Biotechnology		Preferred Stock Warrant			103,679				64				163
PDS Biotechnology Corporation (2)(5)(12)		Biotechnology		Common Stock Warrant			299,848				160				651
Provivi, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			293,488				442				173
Stealth Biotherapeutics Inc. (2)(12)		Biotechnology		Common Stock Warrant			318,181				264				125
vTv Therapeutics Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			95,293				44				—
Xeris Pharmaceuticals, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			126,000				72				58
AccuVein Inc. (2)(12)		Medical Device		Common Stock Warrant			1,175				24				—
Aerin Medical, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			1,818,183				66				1,204
Aerobiotix, LLC (2)(12)		Medical Device		Preferred Stock Warrant			27,330				48				32
Canary Medical Inc. (2)(12)		Medical Device		Preferred Stock Warrant			12,153				86				1,319
Ceribell, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			145,483				69				211
Cognoa, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			4,106,174				145				178
Conventus Orthopaedics, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			7,972,222				221				229
CSA Medical, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			1,375,727				150				154
CVRx, Inc. (2)(5)(12)		Medical Device		Common Stock Warrant			47,410				76				278
Infobionic, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			317,647				124				52
Magnolia Medical Technologies, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			809,931				194				390
Meditrina, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			233,993				83				101
Robin Healthcare, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			86,066				16				16
Scientia Vascular, Inc (2)(12)		Medical Device		Preferred Stock Warrant			27,036				57				64
Sonex Health, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			1,098,805				98				125
VERO Biotech LLC (2)(12)		Medical Device		Preferred Stock Warrant			408				53				1
Swift Health Systems Inc. (2)(12)		Medical Device		Preferred Stock Warrant			135,484				71				84
Total Non-Affiliate Warrants — Life Science											4,199				6,268

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

										Cost of				Fair
Portfolio Company (1)(3)		Sector		Type of Investment (7)		Number of Shares				Investments (6)(9)				Value (9)
Non-Affiliate Warrants — Sustainability — 0.2% (8)
Aerofarms, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			201,537				61				—
LiquiGlide, Inc. (2)(12)		Other Sustainability		Common Stock Warrant			61,359				36				56
Nexii Building Solutions, Inc. (2)(12)(15)		Other Sustainability		Common Stock Warrant			213,746				490				—
Soli Organic, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			681				214				365
Temperpack Technologies, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			34,604				121				266
Total Non-Affiliate Warrants — Sustainability											922				687
Non-Affiliate Warrants — Technology — 4.6% (8)
Axiom Space, Inc. (2)(12)		Communications		Common Stock Warrant			1,991				45				67
Intelepeer Holdings, Inc. (2)(12)		Communications		Preferred Stock Warrant			2,936,535				138				3,272
PebblePost, Inc. (2)(12)		Communications		Preferred Stock Warrant			598,850				92				139
Alula Holdings, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			20,000				93				—
Aterian, Inc. (2)(5)(12)		Consumer-related Technologies		Common Stock Warrant			76,923				195				—
Better Place Forests Co. (12)		Consumer-related Technologies		Preferred Stock Warrant			10,690				26				—
Caastle, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			268,591				67				1,058
CAMP NYC, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			75,997				22				30
Clara Foods Co. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			46,745				30				126
Divergent Technologies, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			37,294				95				276
Havenly, Inc. (2)(12)		Consumer-related Technologies		Common Stock Warrant			1,312,500				2,947				2,677
MyForest Foods Co. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			250				29				61
NextCar Holding Company, Inc. (2)(12)		Consumer-related Technologies		Preferred and Common Stock Warrant			1,237,370				197				—
Optoro, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			11,550				182				182
Primary Kids, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			553,778				57				595
Quip NYC Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			6,191				325				536
Unagi, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			171,081				32				—
Updater, Inc.(2)(12)		Consumer-related Technologies		Common Stock Warrant			108,333				34				11
CPG Beyond, Inc. (2)(12)		Data Storage		Preferred Stock Warrant			500,000				242				912
Silk, Inc. (2)(12)		Data Storage		Preferred Stock Warrant			394,110				175				148
Global Worldwide LLC (2)(12)		Internet and Media		Preferred Stock Warrant			245,810				75				63
Rocket Lawyer Incorporated (2)(12)		Internet and Media		Preferred Stock Warrant			261,721				92				360
Skillshare, Inc. (2)(12)		Internet and Media		Preferred Stock Warrant			139,074				162				1,211
Liqid, Inc. (2)(12)		Networking		Preferred Stock Warrant			344,102				364				247
Halio, Inc. (2)(12)		Power Management		Preferred Stock Warrant			5,002,574				1,585				2,898
Avalanche Technology, Inc. (2)(12)		Semiconductors		Preferred and Common Stock Warrant			6,081				57				—
BriteCore Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			77,828				21				70
Dropoff, Inc. (2)(12)		Software		Common Stock Warrant			516,732				455				169
E La Carte, Inc. (2)(5)(12)		Software		Common Stock Warrant			147,361				60				121
Everstream Holdings, LLC (2)(12)		Software		Preferred Stock Warrant			350,000				70				70
Kodiak Robotics, Inc. (2)(12)		Software		Preferred Stock Warrant			639,918				273				299
Lemongrass Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			101,308				34				41
Lotame Solutions, Inc. (2)(12)		Software		Preferred Stock Warrant			71,305				21				57
Lytics, Inc. (2)(12)		Software		Preferred Stock Warrant			85,543				46				18
Noodle Partners, Inc. (2)(12)		Software		Preferred Stock Warrant			84,037				116				120
Reputation Institute, Inc. (2)(12)		Software		Preferred Stock Warrant			3,731				56				50
Revinate Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			682,034				44				101
SIGNiX, Inc. (12)		Software		Preferred Stock Warrant			186,235				225				—
Slingshot Aerospace, Inc. (2)(12)		Software		Preferred Stock Warrant			309,208				123				135
Supply Network Visibility Holdings LLC (2)(12)		Software		Preferred Stock Warrant			682				64				140
Topia Mobility, Inc. (2)(12)		Software		Preferred Stock Warrant			3,049,607				138				—
Viken Detection Corporation (2)(12)		Software		Preferred Stock Warrant			345,443				120				120
xAd, Inc. (2)(12)		Software		Preferred Stock Warrant			4,343,348				177				12
Total Non-Affiliate Warrants — Technology											9,401				16,392

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments (Unaudited)

June 30, 2023

(Dollars in thousands)

										Cost of				Fair
Portfolio Company (1)(3)		Sector		Type of Investment (7)		Number of Shares				Investments (6)(9)				Value (9)
Non-Affiliate Warrants — Healthcare information and services — 0.6% (8)
Hound Labs, Inc (2) (12)		Diagnostics		Preferred Stock Warrant			171,370				47				56
Kate Farms, Inc. (2)(12)		Other Healthcare		Preferred Stock Warrant			82,965				101				1,374
BrightInsight, Inc. (2)(12)		Software		Preferred Stock Warrant			85,066				167				181
Medsphere Systems Corporation (2)(12)		Software		Preferred Stock Warrant			7,097,792				61				362
SafelyYou, Inc. (2)(12)		Software		Preferred Stock Warrant			150,353				163				163
Total Non-Affiliate Warrants — Healthcare information and services											539				2,136
Total Non-Affiliate Warrants											15,061				25,483
Non-Affiliate Other Investments — 0.4% (8)
Lumithera, Inc. (12)		Medical Device		Royalty Agreement							1,200				1,100
ZetrOZ, Inc. (12)		Medical Device		Royalty Agreement							—				200
Total Non-Affiliate Other Investments											1,200				1,300
Non-Affiliate Equity — 1.2% (8)
Castle Creek Biosciences, Inc. (12)		Biotechnology		Common Stock			1,162				250				250
Emalex Biosciences, Inc. (12)		Biotechnology		Common Stock			32,831				356				356
Getaround, Inc. (2)(5)		Consumer-related Technologies		Common Stock			87,082				253				30
NextCar Holding Company, Inc. (2)(12)		Technology		Preferred Stock			2,688,971				89				89
SnagAJob.com, Inc. (12)		Consumer-related Technologies		Common Stock			82,974				9				83
Lumithera, Inc. (12)		Medical Device		Common Stock			392,651				2,000				1,700
Tigo Energy, Inc. (5)(12)		Other Sustainability		Common Stock			5,205				111				97
Branded Online, Inc. (2)(5)		Software		Common Stock			5,398				1,079				8
Decisyon, Inc. (12)		Software		Preferred Stock			280,000				2,800				1,281
Lotame, Inc. (12)		Software		Preferred Stock			66,127				2				193
Axiom Space, Inc. (12)		Technology		Preferred Stock			1,810				261				306
Total Non-Affiliate Equity											7,210				4,393
Total Non-Affiliate Portfolio Investment Assets										$	723,633			$	714,485
Non-controlled Affiliate Investments — 0.3% (8)
Non-controlled Affiliate Equity — Life Science —0.3% (8)
Cadrenal Therapeutics, Inc. (5)		Biotechnology		Common Stock			600,000				—				906
Total Non-Controlled Affiliate Equity										$	—				906
Total Non-Controlled Affiliate Portfolio Investment Assets										$	—				906
Total Portfolio Investment Assets — 201.4% (8)										$	723,633			$	715,391

(1) All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business in the United States, unless otherwise noted.

(2) Has been pledged as collateral under the revolving credit facility (the “Key Facility”) with KeyBank National Association (“Key”), the Note Funding Agreement (the “NYL Facility”, together with the Key Facility, the "Credit Facilities") with several entities owned or affiliated with New York Life Insurance Company (“NYL Noteholders”), the term debt securitization in connection with which an affiliate of the Company made an offering of $100.0 million in aggregate principal amount of fixed rate asset-backed notes that were issued in conjunction with the $160.0 million securitization of secured loans the Company completed on August 13, 2019 (the “2019 Asset-Backed Notes”), and/or the term debt securitization in connection with which an affiliate of the Company made an offering of $100.0 million in aggregate principal amount of fixed rate asset-backed notes that were issued in conjunction with the $157.8 million securitization of secured loans the Company completed on November 9, 2022 (the “2022 Asset-Backed Notes”).

(3) All non-affiliate investments are investments in which the Company owns less than 5% of the voting securities of the portfolio company. All non-controlled affiliate investments are investments in which the Company owns 5% or more of the voting securities of the portfolio company but not more than 25% of the voting securities of the portfolio company. All controlled affiliate investments are investments in which the Company owns more than 25% of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement).

(4) All interest is payable in cash due monthly in arrears, unless otherwise indicated, and applies only to the Company’s debt investments. Interest rate is the annual interest rate on the debt investment and does not include end-of-term payments (“ETPs”), and any additional fees related to the investments, such as deferred interest, commitment fees or prepayment fees. Debt investments are at variable rates for the term of the debt investment, unless otherwise indicated. For each debt investment, the current interest rate in effect as of  June 30, 2023 is provided.

(5) Portfolio company is a public company.

(6) For debt investments, represents principal balance less unearned income.

(7) Warrants, Equity and Other Investments are non-income producing.

(8) Value as a percent of net assets.

(9) As of June 30, 2023, 6.4% and 5.3% of the Company’s total assets on a cost and fair value basis, respectively, are in non-qualifying assets. Under the 1940 Act, the Company may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company’s total assets.

(10) ETPs are contractual fixed-interest payments due in cash at the maturity date of the applicable debt investment, including upon any prepayment, and are a fixed percentage of the original principal balance of the debt investments unless otherwise noted. Interest will accrue during the life of the debt investment on each ETP and will be recognized as non-cash income until it is actually paid. Therefore, a portion of the incentive fee the Company may pay its Advisor will be based on income that the Company has not yet received in cash.

(11) Debt investment has a payment-in-kind (“PIK”) feature. PIK interest is accrued, added to the principal balance of the debt investment, and payable at maturity.

(12) The fair value of the investment was valued using significant unobservable inputs.

(13) Debt investment is on non-accrual status as of June 30, 2023.

(14)	Debt investment sold to third party on July 3, 2023.
(15)	Entity is organized under the laws of Canada and has a principal place of business in Canada.

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Non-Affiliate Investments — 226.1% (8)
Non-Affiliate Debt Investments — 215.5% (8)
Non-Affiliate Debt Investments — Life Science — 99.7% (8)
Avalo Therapeutics, Inc. (2)(5)(12)		Biotechnology		Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025		$	2,885			$	2,853			$	2,777
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025			2,885				2,823				2,750
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		January 1, 2025			1,442				1,411				1,374
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		February 1, 2025			2,885				2,821				2,748
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		February 1, 2025			2,885				2,821				2,748
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		April 1, 2025			1,442				1,408				1,371
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				3.00	%		April 1, 2025			1,442				1,408				1,371
Castle Creek Biosciences, Inc. (2)(12)		Biotechnology		Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,891				4,891
				Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,963				4,963
				Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			3,000				2,978				2,978
				Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,963				4,963
				Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			5,000				4,963				4,963
				Term Loan			12.50	%	Prime			6.05	%			9.55	%			13.50	%			5.50	%		May 1, 2026			3,000				2,978				2,978
Emalex Biosciences, Inc. (2)(12)		Biotechnology		Term Loan			12.07	%	Libor			7.90	%			9.75	%			-				5.00	%		June 1, 2024			1,979				1,962				1,962
				Term Loan			12.07	%	Libor			7.90	%			9.75	%			-				5.00	%		June 1, 2024			1,979				1,963				1,963
				Term Loan			12.07	%	Libor			7.90	%			9.75	%			-				5.00	%		November 1, 2025			5,000				4,923				4,923
				Term Loan			12.07	%	Libor			7.90	%			9.75	%			-				5.00	%		May 1, 2026			5,000				4,912				4,912
Evelo Biosciences, Inc. (2)(5)(12)		Biotechnology		Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			10,000				9,872				9,872
				Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			15,000				14,808				14,808
				Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			6,000				5,923				5,923
				Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			6,000				5,923				5,923
				Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			4,000				3,949				3,949
				Term Loan			11.75	%	Prime			4.75	%			11.00	%			-				4.25	%		January 1, 2028			4,000				3,949				3,949
F-Star Therapeutics, Inc. (2)(5)(12)		Biotechnology		Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		April 1, 2025			2,500				2,476				2,476
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		July 1, 2025			2,500				2,473				2,473
Greenlight Biosciences, Inc. (2)(5)(12)		Biotechnology		Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				3.00	%		July 1, 2025			5,000				4,857				4,857
				Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				3.00	%		July 1, 2025			2,500				2,430				2,430
IMV Inc. (2)(5)(12)(14)		Biotechnology		Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				5.00	%		July 1, 2025			5,000				4,946				4,946
				Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				5.00	%		July 1, 2025			2,500				2,473				2,473
				Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				5.00	%		January 1, 2026			5,000				4,947				4,947
				Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				5.00	%		January 1, 2026			5,000				4,947				4,947
KSQ Therapeutics, Inc. (2) (12)		Biotechnology		Term Loan			12.25	%	Prime			4.75	%			8.50	%			-				5.50	%		May 1, 2027			6,250				6,077				6,077
				Term Loan			12.25	%	Prime			4.75	%			8.50	%			-				5.50	%		May 1, 2027			6,250				6,177				6,177
Native Microbials, Inc (2) (12)		Biotechnology		Term Loan			12.75	%	Prime			5.25	%			8.50	%			-				5.00	%		November 1, 2026			3,750				3,630				3,630
				Term Loan			12.75	%	Prime			5.25	%			8.50	%			-				5.00	%		November 1, 2026			2,500				2,469				2,469
PDS Biotechnology Corporation (2)(5)(12)		Biotechnology		Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			10,000				9,701				9,701
				Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			3,750				3,697				3,697
				Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				3.75	%		September 1, 2026			3,750				3,697				3,697
Provivi, Inc. (2)(12)		Biotechnology		Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			4,667				4,597				4,597
				Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			4,667				4,597				4,597
				Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,280				2,280
				Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,280				2,280
				Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,274				2,274
				Term Loan			12.67	%	Libor			8.50	%			9.50	%			-				5.50	%		December 1, 2024			2,333				2,274				2,274
Stealth Biotherapeutics Inc. (2)(12)		Biotechnology		Term Loan			13.00	%	Prime			5.50	%			8.75	%			-				6.00	%		October 1, 2025			5,000				4,914				4,914
				Term Loan			13.00	%	Prime			5.50	%			8.75	%			-				6.00	%		October 1, 2025			2,500				2,457				2,457
Aerobiotix, LLC (2)(12)		Medical Device		Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				6.00	%		April 1, 2026			2,500				2,463				2,364
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				6.00	%		April 1, 2026			2,500				2,463				2,364
Canary Medical Inc. (2)(12)		Medical Device		Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				7.00	%		November 1, 2024			2,500				2,475				2,475
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				7.00	%		November 1, 2024			2,500				2,489				2,489
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				7.00	%		November 1, 2024			2,500				2,473				2,473
Ceribell, Inc. (2)(12)		Medical Device		Term Loan			10.50	%	Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			5,000				4,973				4,973
				Term Loan			10.50	%	Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			5,000				4,973				4,973
				Term Loan			10.50	%	Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			2,500				2,478				2,478
				Term Loan			10.50	%	Prime			3.50	%			8.25	%			-				5.50	%		October 1, 2024			2,500				2,478				2,478
Cognoa, Inc. (2)(12)		Medical Device		Term Loan			13.00	%	Prime			5.50	%			8.75	%			-				6.00	%		August 1, 2026			2,500				2,466				2,466
				Term Loan			13.00	%	Prime			5.50	%			8.75	%			-				6.00	%		August 1, 2026			5,000				4,932				4,932
Conventus Orthopaedics, Inc. (2)(12)		Medical Device		Term Loan			12.17	%	Libor			8.00	%			9.25	%			-				10.36	%		July 1, 2025			3,960				3,898				3,898
				Term Loan			12.17	%	Libor			8.00	%			9.25	%			-				10.36	%		July 1, 2025			3,960				3,898				3,898

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Corinth Medtech, Inc. (2)(12)		Medical Device		Term Loan			12.25	%	Prime			5.25	%			8.50	%			-				20.00	%		September 15, 2022			2,500				2,500				2,500
				Term Loan			12.25	%	Prime			5.25	%			8.50	%			-				20.00	%		September 15, 2022			2,500				2,500				2,500
CSA Medical, Inc. (2)(12)		Medical Device		Term Loan			12.37	%	Libor			8.20	%			10.00	%			-				5.00	%		January 1, 2024			1,625				1,610				1,610
				Term Loan			12.37	%	Libor			8.20	%			10.00	%			-				5.00	%		January 1, 2024			108				107				107
				Term Loan			12.37	%	Libor			8.20	%			10.00	%			-				5.00	%		March 1, 2024			2,000				1,983				1,983
Embody, Inc. (2)(12)		Medical Device		Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				28.00	%		August 1, 2026			2,500				2,482				2,482
InfoBionic, Inc. (2)(12)		Medical Device		Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		October 1, 2024			3,208				3,143				3,143
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		June 1, 2025			1,000				974				974
Magnolia Medical Technologies, Inc. (2)(12)		Medical Device		Term Loan			12.00	%	Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,939				4,939
				Term Loan			12.00	%	Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,939				4,939
				Term Loan			12.00	%	Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,933				4,933
				Term Loan			12.00	%	Prime			5.00	%			9.75	%			-				4.00	%		March 1, 2025			5,000				4,933				4,933
				Term Loan			12.50	%	Prime			5.00	%			9.75	%			-				4.00	%		January 1, 2027			5,000				4,913				4,913
				Term Loan			12.50	%	Prime			5.00	%			9.75	%			-				4.00	%		January 1, 2027			5,000				4,913				4,913
Robin Healthcare, Inc. (2)(12)		Medical Device		Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		November 1, 2026			3,500				3,360				3,360
				Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		November 1, 2026			3,500				3,460				3,460
Scientia Vascular, Inc. (2)(12)		Medical Device		Term Loan			11.75	%	Prime			4.75	%			8.50	%			-				5.00	%		January 1, 2027			3,750				3,597				3,597
				Term Loan			11.75	%	Prime			4.75	%			8.50	%			-				5.00	%		January 1, 2027			3,750				3,706				3,706
Sonex Health, Inc. (2)(12)		Medical Device		Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,476				2,476
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,476				2,476
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				8.00	%		June 1, 2025			2,500				2,476				2,476
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				8.00	%		April 1, 2026			2,500				2,453				2,453
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				8.00	%		May 1, 2026			2,500				2,455				2,455
Spineology, Inc. (2)(12)		Medical Device		Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				1.00	%		October 1, 2025			5,000				4,966				4,966
				Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				1.00	%		April 1, 2026			2,500				2,481				2,481
Swift Health Systems Inc. (2)(12)		Medical Device		Term Loan			12.25	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,349				3,349
				Term Loan			12.25	%	Prime			5.25	%			9.00	%			-				5.00	%		July 1, 2027			3,500				3,454				3,454
Total Non-Affiliate Debt Investments — Life Science																																		318,172				317,568
Non-Affiliate Debt Investments — Sustainability — 26.3% (8)
Aerofarms, Inc. (2)(12)		Other Sustainability		Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				3.00	%		April 1, 2026			3,750				3,699				3,699
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				3.00	%		April 1, 2026			3,750				3,699				3,699
Nexii Building Solutions, Inc. (2)(12)(14)		Other Sustainability		Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				2.50	%		September 1, 2025			7,500				7,371				7,371
				Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				2.50	%		September 1, 2025			7,500				7,371				7,371
				Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				2.50	%		September 1, 2025			7,500				7,371				7,371
				Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				2.50	%		July 1, 2026			5,000				4,903				4,903
				Term Loan			14.50	%	Prime			7.00	%			10.25	%			-				2.50	%		July 1, 2026			5,000				4,903				4,903
Soli Organic, Inc. (2)(12)		Other Sustainability		Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.75	%		April 1, 2026			2,500				2,463				2,463
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.75	%		April 1, 2026			5,000				4,927				4,927
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.75	%		May 1, 2026			5,000				4,924				4,924
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.75	%		May 1, 2026			2,500				2,462				2,462
				Term Loan			13.00	%	Prime			5.50	%			10.00	%			-				2.75	%		December 1, 2026			5,000				4,900				4,900
				Term Loan			13.00	%	Prime			5.50	%			10.00	%			-				2.75	%		December 1, 2026			2,500				2,450				2,450
Temperpack Technologies, Inc. (2)(12)		Other Sustainability		Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.50	%		June 1, 2025			3,750				3,697				3,697
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.50	%		June 1, 2025			3,750				3,717				3,717
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2025			7,500				7,424				7,424
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2025			3,750				3,712				3,712
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				2.50	%		October 1, 2025			3,750				3,712				3,712
Total Non-Affiliate Debt Investments — Sustainability																																		83,705				83,705
Non-Affiliate Debt Investments — Technology — 81.4% (8)
Axiom Space, Inc. (2)(12)		Communications		Term Loan			13.00	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,455				7,455
				Term Loan			13.00	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,455				7,455
				Term Loan			13.00	%	Prime			6.00	%			9.25	%			-				2.50	%		June 1, 2026			7,500				7,455				7,455
				Convertible Note			3.00	%																			July 1, 2023			250				250				306
Alula Holdings, Inc. (2)(12)		Consumer-related Technologies		Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				3.00	%		January 1, 2025			5,000				4,966				4,966
				Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				3.00	%		January 1, 2025			5,000				4,966				4,966
				Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				3.00	%		January 1, 2025			3,000				2,979				2,979
				Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				3.00	%		December 1, 2025			1,000				976				976
				Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				3.00	%		February 1, 2026			1,000				977				977
Better Place Forests Co. (2)(12)(13)		Consumer-related Technologies		Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				1.85	%		July 1, 2025			5,000				4,951				3,834
				Term Loan			13.75	%	Prime			6.25	%			9.50	%			-				1.85	%		October 1, 2025			2,500				2,474				1,916
CAMP NYC, Inc. (2)(12)		Consumer-related Technologies		Term Loan			14.75	%	Prime			7.25	%			10.50	%			-				3.00	%		May 1, 2026			3,500				3,461				3,461
Clara Foods Co. (2)(12)		Consumer-related Technologies		Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				5.50	%		August 1, 2025			2,500				2,482				2,482
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				5.50	%		August 1, 2025			2,500				2,482				2,482

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

Portfolio Company (1)(3)		Sector		Type of Investment (7)		Cash Rate (4)			Index		Margin				Floor				Ceiling				ETP (10)				Maturity Date		Principal Amount				Cost of Investments (6)(9)				Fair Value (9)
Divergent Technologies, Inc. (2)(12)		Consumer-related Technologies		Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,478				3,478
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,238				1,238
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,715				3,715
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,238				1,238
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			3,750				3,715				3,715
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		July 1, 2027			1,250				1,238				1,238
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		January 1, 2028			3,750				3,698				3,698
				Term Loan			11.25	%	Prime			6.00	%			9.50	%			11.25	%			3.00	%		January 1, 2028			3,750				3,698				3,698
Havenly, Inc. (2)(12)		Consumer-related Technologies		Term Loan			12.50	%	Prime			5.00	%			5.00	%			-				4.00	%		March 1, 2027			2,000				1,082				1,082
				Term Loan			12.50	%	Prime			5.00	%			5.00	%			-				4.00	%		March 1, 2027			3,000				1,623				1,623
				Term Loan			11.00	%	Prime			3.50	%			10.50	%			-				7.78	%		February 1, 2028			2,813				2,813				2,813
				Term Loan			11.00	%	Prime			3.50	%			10.50	%			-				7.78	%		February 1, 2028			2,813				2,813				2,813
Interior Define, Inc. (2)(12)(13)		Consumer-related Technologies		Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		January 1, 2026			3,210				3,151				—
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		January 1, 2026			2,963				2,886				—
Lyrical Foods, Inc. (2)(12)		Consumer-related Technologies		Term Loan			10.00	%	Prime			6.75	%			10.00	%			-				-			September 1, 2027			2,500				2,588				2,279
MyForest Foods Co. (2)(12)		Consumer-related Technologies		Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				3.00	%		October 1, 2025			5,000				4,954				4,954
				Term Loan			14.25	%	Prime			6.75	%			10.00	%			-				3.00	%		October 1, 2025			2,500				2,477				2,477
NextCar Holding Company, Inc. (2)(12)		Consumer-related Technologies		Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			5,000				4,943				4,715
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			2,000				1,981				1,890
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			2,500				2,477				2,363
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			3,000				2,971				2,835
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			2,500				2,459				2,345
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			2,500				2,459				2,345
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			5,000				4,914				4,688
				Term Loan			12.75	%	Prime			5.75	%			9.00	%			-				2.00	%		December 30, 2022			2,500				2,456				2,342
Optoro, Inc. (2)(12)		Consumer-related Technologies		Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		August 1, 2027			2,500				2,347				2,347
Primary Kids, Inc. (2)(12)		Consumer-related Technologies		Term Loan			14.25	%	Prime			7.25	%			10.50	%			-				3.00	%		March 1, 2025			2,700				2,673				2,673
				Term Loan			14.25	%	Prime			7.25	%			10.50	%			-				3.00	%		March 1, 2025			2,700				2,673				2,673
				Term Loan			14.25	%	Prime			7.25	%			10.50	%			-				3.00	%		September 1, 2025			3,000				2,967				2,967
Unagi, Inc. (2)(12)		Consumer-related Technologies		Term Loan			15.25	%	Prime			7.75	%			11.00	%			-				-			July 1, 2025			2,500				2,473				2,473
				Term Loan			15.25	%	Prime			7.75	%			11.00	%			-				-			July 1, 2025			1,250				1,236				1,236
				Term Loan			15.25	%	Prime			7.75	%			11.00	%			-				-			July 1, 2025			1,250				1,236				1,236
Liqid, Inc. (2)(12)		Networking		Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			3,333				3,286				3,286
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			3,333				3,286				3,286
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,667				1,641				1,641
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,667				1,641				1,641
				Term Loan			13.25	%	Prime			6.25	%			9.50	%			-				4.00	%		September 1, 2024			1,667				1,613				1,613
BriteCore Holdings, Inc. (2)(12)		Software		Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				5.00	%		March 1, 2026			2,500				2,421				2,421
				Term Loan			13.75	%	Prime			6.75	%			10.00	%			-				5.00	%		March 1, 2026			2,500				2,487				2,487
Decisyon, Inc. (12)		Software		Term Loan			16.93	%	Prime			9.43	%			12.68	%			-				50.43	%		December 31, 2022			3,295				3,295				3,295
Dropoff, Inc. (2)(12)		Software		Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				3.50	%		April 1, 2026			6,500				6,347				6,347
				Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				3.50	%		April 1, 2026			6,000				5,859				5,859
				Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				3.50	%		August 1, 2026			2,500				2,436				2,436
Engage3, LLC (2)(12)		Software		Term Loan			13.25	%	Prime			6.25	%			9.75	%			-				4.50	%		July 1, 2027			3,750				3,678				3,678
				Term Loan			13.25	%	Prime			6.25	%			9.75	%			-				4.50	%		July 1, 2027			3,750				3,718				3,718
Groundspeed Analytics, Inc. (2)(12)		Software		Term Loan			13.00	%	Prime			5.50	%			11.00	%			18.00	%			3.00	%		December 1, 2026			5,000				4,798				4,798
				Term Loan			13.00	%	Prime			5.50	%			11.00	%			18.00	%			3.00	%		December 1, 2026			5,000				4,948				4,948
Kodiak Robotics, Inc. (2)(12)		Software		Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			10,000				9,826				9,826
				Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			10,000				9,826				9,826
				Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			5,000				4,913				4,913
				Term Loan			13.00	%	Prime			5.50	%			10.25	%			-				4.00	%		April 1, 2026			5,000				4,913				4,913
Lemongrass Holdings, Inc. (2)(12)		Software		Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				2.50	%		March 1, 2026			5,000				4,947				4,947
				Term Loan			14.00	%	Prime			6.50	%			9.75	%			-				2.50	%		March 1, 2026			2,500				2,474				2,474
Lytics, Inc. (2)(12)		Software		Term Loan			13.00	%	Prime			6.00	%			9.25	%			-				3.00	%		July 1, 2025			2,500				2,396				2,396
				Term Loan			13.00	%	Prime			6.00	%			12.25	%			-				3.00	%		December 1, 2026			1,250				1,231				1,231
Reputation Institute, Inc. (2)(12)		Software		Term Loan			14.25	%	Prime			7.25	%			10.50	%			-				3.00	%		August 1, 2025			5,000				4,932				4,932
Slingshot Aerospace, Inc. (2)(12)		Software		Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,870				4,870
				Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,933				4,933
				Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,933				4,933
				Term Loan			13.25	%	Prime			5.75	%			9.75	%			-				5.00	%		August 1, 2026			5,000				4,933				4,933
Supply Network Visiblity Holdings LLC (2)(12)		Software		Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		February 1, 2025			3,500				3,472				3,472
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		February 1, 2025			3,500				3,472				3,472
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		December 1, 2025			2,500				2,472				2,472
				Term Loan			13.50	%	Prime			6.50	%			9.75	%			-				4.00	%		December 1, 2025			2,500				2,472				2,472
Total Non-Affiliate Debt Investments — Technology																																		268,468				259,366
Non-Affiliate Debt Investments — Healthcare information and services — 8.1% (8)
Hound Labs inc. (2) (12)		Diagnostics		Term Loan			13.50	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			2,500				2,385				2,385
				Term Loan			13.50	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			2,500				2,473				2,473
				Term Loan			13.50	%	Prime			6.00	%			9.25	%			-				3.50	%		June 1, 2026			5,000				4,946				4,946
Secure Transfusion Services, Inc. (2)(12)(13)		Other Healthcare		Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				4.00	%		October 1, 2025			4,943				4,943				1,668
				Term Loan			13.25	%	Prime			5.75	%			9.00	%			-				4.00	%		December 31, 2025			2,500				2,467				832
BrightInsight, Inc. (2)(12)		Software		Term Loan			12.50	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			7,000				6,619				6,619
				Term Loan			12.50	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			3,500				3,448				3,448
				Term Loan			12.50	%	Prime			5.50	%			9.50	%			-				3.00	%		August 1, 2027			3,500				3,448				3,448
Total Non-Affiliate Debt Investments — Healthcare information and services																																		30,729				25,819
Total Non- Affiliate Debt Investments																																		701,074				686,458

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

										Cost of				Fair
Portfolio Company (1)(3)		Sector		Type of Investment (7)		Number of Shares				Investments (6)(9)				Value (9)
Non-Affiliate Warrant Investments — 9.4% (8)
Non-Affiliate Warrants — Life Science — 3.1% (8)
Avalo Therapeutics, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			26,442				311				—
Castle Creek Biosciences, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			7,404				214				335
Corvium, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			661,956				53				—
Emalex Biosciences, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			110,402				176				263
Evelo Biosciences, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			463,915				126				125
F-Star Therapeutics, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			21,120				35				—
Greenlight Biosciences, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			47,452				366				—
Imunon, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			16,502				66				—
IMV Inc. (2)(5)(12)(14)		Biotechnology		Common Stock Warrant			39,774				67				—
KSQ Therapeutics, Inc. (2) (12)		Biotechnology		Preferred Stock Warrant			48,077				51				60
Mustang Bio, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			252,161				146				—
Native Microbials, Inc (2) (12)		Biotechnology		Preferred Stock Warrant			103,679				64				162
PDS Biotechnology Corporation (2)(5)(12)		Biotechnology		Common Stock Warrant			299,848				160				3,024
Provivi, Inc. (2)(12)		Biotechnology		Preferred Stock Warrant			203,017				399				648
Rocket Pharmaceuticals Corporation (5)(12)		Biotechnology		Common Stock Warrant			7,051				17				14
Stealth Biotherapeutics Inc. (2)(12)		Biotechnology		Common Stock Warrant			318,181				264				37
vTv Therapeutics Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			95,293				44				—
Xeris Pharmaceuticals, Inc. (2)(5)(12)		Biotechnology		Common Stock Warrant			126,000				72				3
AccuVein Inc. (2)(12)		Medical Device		Common Stock Warrant			1,175				24				—
Aerin Medical, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			1,818,183				64				1,200
Aerobiotix, LLC (2)(12)		Medical Device		Preferred Stock Warrant			27,330				48				31
Canary Medical Inc. (2)(12)		Medical Device		Preferred Stock Warrant			12,153				84				1,864
Ceribell, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			145,483				69				209
Cognoa, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			775,000				148				179
Conventus Orthopaedics, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			7,972,222				221				226
CSA Medical, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			1,375,727				153				150
CVRx, Inc. (2)(5)(12)		Medical Device		Common Stock Warrant			47,410				76				394
Infobionic, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			317,647				124				113
Magnolia Medical Technologies, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			809,931				194				385
Meditrina, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			233,993				83				101
Robin Healthcare, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			86,066				16				16
Scientia Vascular, Inc (2)(12)		Medical Device		Preferred Stock Warrant			19,662				40				46
Sonex Health, Inc. (2)(12)		Medical Device		Preferred Stock Warrant			605,313				98				123
VERO Biotech LLC (2)(12)		Medical Device		Preferred Stock Warrant			408				53				1
Swift Health Systems Inc. (2)(12)		Medical Device		Preferred Stock Warrant			135,484				71				83
Total Non-Affiliate Warrants — Life Science											4,197				9,792
Non-Affiliate Warrants — Sustainability — 0.6% (8)
Aerofarms, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			201,537				61				74
LiquiGlide, Inc. (2)(12)		Other Sustainability		Common Stock Warrant			61,539				39				55
Nexii Building Solutions, Inc. (2)(12)(14)		Other Sustainability		Common Stock Warrant			204,832				488				1,061
Soli Organic, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			681				214				361
Temperpack Technologies, Inc. (2)(12)		Other Sustainability		Preferred Stock Warrant			35,906				126				268
Total Non-Affiliate Warrants — Sustainability											928				1,819

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

										Cost of				Fair
Portfolio Company (1)(3)		Sector		Type of Investment (7)		Number of Shares				Investments (6)(9)				Value (9)
Non-Affiliate Warrants — Technology — 5.1% (8)
Axiom Space, Inc. (2)(12)		Communications		Common Stock Warrant			1,991				46				67
Intelepeer Holdings, Inc. (2)(12)		Communications		Preferred Stock Warrant			2,936,535				139				3,265
PebblePost, Inc. (2)(12)		Communications		Preferred Stock Warrant			598,850				92				173
Alula Holdings, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			20,000				93				64
Aterian, Inc. (2)(5)(12)		Consumer-related Technologies		Common Stock Warrant			76,923				195				—
Better Place Forests Co. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			10,690				26				—
Caastle, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			268,591				68				1,069
CAMP NYC, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			17,605				20				61
Clara Foods Co. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			46,745				30				125
Divergent Technologies, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			31,966				56				233
Havenly, Inc. (2)(12)		Consumer-related Technologies		Common Stock Warrant			1,312,500				2,947				2,947
Interior Define, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			553,710				103				—
MyForest Foods Co. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			143				29				37
NextCar Holding Company, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			1,261,253				197				17
Optoro, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			6,600				104				104
Primary Kids, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			553,778				57				429
Quip NYC Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			6,191				325				534
Unagi, Inc. (2)(12)		Consumer-related Technologies		Preferred Stock Warrant			171,081				32				22
Updater, Inc.(2)(12)		Consumer-related Technologies		Common Stock Warrant			108,333				34				42
CPG Beyond, Inc. (2)(12)		Data Storage		Preferred Stock Warrant			500,000				242				909
Silk, Inc. (2)(12)		Data Storage		Preferred Stock Warrant			442,110				234				407
Global Worldwide LLC (2)(12)		Internet and Media		Preferred Stock Warrant			245,810				75				—
Rocket Lawyer Incorporated (2)(12)		Internet and Media		Preferred Stock Warrant			261,721				92				357
Skillshare, Inc. (2)(12)		Internet and Media		Preferred Stock Warrant			139,074				162				802
Liqid, Inc. (2)(12)		Networking		Preferred Stock Warrant			344,102				364				243
Halio, Inc. (2)(12)		Power Management		Preferred Stock Warrant			5,002,574				1,585				2,610
Avalanche Technology, Inc. (2)(12)		Semiconductors		Preferred and Common Stock Warrants			6,081				56				—
BriteCore Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			77,828				21				69
Decisyon, Inc. (12)		Software		Common Stock Warrant			82,967				46				—
Dropoff, Inc. (2)(12)		Software		Common Stock Warrant			516,732				455				197
E La Carte, Inc. (2)(5)(12)		Software		Common Stock Warrant			147,361				60				3
Groundspeed Analytics, Inc. (2)(12)		Software		Preferred Stock Warrant			86,300				6				6
Kodiak Robotics, Inc. (2)(12)		Software		Preferred Stock Warrant			639,918				273				296
Lemongrass Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			101,308				34				41
Lotame Solutions, Inc. (2)(12)		Software		Preferred Stock Warrant			288,115				22				312
Lytics, Inc. (2)(12)		Software		Preferred Stock Warrant			80,197				40				44
Reputation Institute, Inc. (2)(12)		Software		Preferred Stock Warrant			3,731				56				39
Revinate Holdings, Inc. (2)(12)		Software		Preferred Stock Warrant			682,034				46				99
Riv Data Corp. (2)(12)		Software		Preferred Stock Warrant			321,428				12				296
SIGNiX, Inc. (12)		Software		Preferred Stock Warrant			186,235				225				—
Skyword, Inc. (12)		Software		Preferred and Common Stock Warrants			301,055				48				1
Slingshot Aerospace, Inc. (2)(12)		Software		Preferred Stock Warrant			309,208				123				133
Supply Network Visiblity Holdings LLC (2)(12)		Software		Preferred Stock Warrant			682				64				83
Topia Mobility, Inc. (2)(12)		Software		Preferred Stock Warrant			3,049,607				138				—
xAd, Inc. (2)(12)		Software		Preferred Stock Warrant			4,343,348				177				12
Total Non-Affiliate Warrants — Technology											9,249				16,148
Non-Affiliate Warrants — Healthcare information and services — 0.6% (8)
Hound Labs, Inc (2) (12)		Diagnostics		Preferred Stock Warrant			159,893				47				54
Kate Farms, Inc. (2)(12)		Other Healthcare		Preferred Stock Warrant			82,965				102				1,370
Secure Transfusion Services, Inc. (2)(12)		Other Healthcare		Preferred Stock Warrant			77,690				47				—
BrightInsight, Inc. (2)(12)		Software		Preferred Stock Warrant			80,544				160				170
Medsphere Systems Corporation (2)(12)		Software		Preferred Stock Warrant			7,097,792				60				359
Total Non-Affiliate Warrants — Healthcare information and services											416				1,953
Total Non-Affiliate Warrants											14,790				29,712
Non-Affiliate Other Investments — 0.4% (8)
Lumithera, Inc. (2)		Medical Device		Royalty Agreement							1,200				1,100
ZetrOZ, Inc. (12)		Medical Device		Royalty Agreement							—				200
Total Non-Affiliate Other Investments											1,200				1,300
Non-Affiliate Equity — 0.8% (8)
Castle Creek Biosciences, Inc. (12)		Biotechnology		Common Stock			1,162				250				250
Emalex Biosciences, Inc. (2)(12)		Biotechnology		Common Stock			32,831				356				356
Getaround, Inc. (2)(5)		Consumer-related Technologies		Common Stock			87,082				253				57
SnagAJob.com, Inc. (12)		Consumer-related Technologies		Common Stock			82,974				8				83
Lumithera, Inc. (2)		Medical Device		Common Stock			392,651				2,000				1,700
Tigo Energy, Inc. (2)		Other Sustainability		Preferred			22,313				8				27
Branded Online, Inc. (2)(5)		Software		Common Stock			108,004				1,079				83
Decisyon, Inc. (12)		Software		Preferred and Common Stock			72,638,663				230				—
Total Non-Affiliate Equity											4,184				2,556
Total Non-Affiliate Portfolio Investment Assets										$	721,248			$	720,026
Total Portfolio Investment Assets — 226.1% (8)										$	721,248			$	720,026

(1) All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business in the United States, unless otherwise noted.

(2) Has been pledged as collateral under the Key Facility, the NYL Facility the 2019 Asset-Backed Notes and/or the 2022 Asset-Backed Notes.

See Notes to Consolidated Financial Statements

Consolidated Schedule of Investments

December 31, 2022

(Dollars in thousands)

(3) All non-affiliate investments are investments in which the Company owns less than 5% of the voting securities of the portfolio company. All non-controlled affiliate investments are investments in which the Company owns 5% or more of the voting securities of the portfolio company but not more than 25% of the voting securities of the portfolio company. All controlled affiliate investments are investments in which the Company owns more than 25% of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement).

(4) All interest is payable in cash due monthly in arrears, unless otherwise indicated, and applies only to the Company’s debt investments. Interest rate is the annual interest rate on the debt investment and does not include ETPs, and any additional fees related to the investments, such as deferred interest, commitment fees or prepayment fees. Debt investments are at variable rates for the term of the debt investment, unless otherwise indicated. All debt investments based on the LIBOR are based on one-month LIBOR. For each debt investment, the current interest rate in effect as of  December 31, 2022 is provided.

(5) Portfolio company is a public company.

(6) For debt investments, represents principal balance less unearned income.

(7) Warrants, Equity and Other Investments are non-income producing.

(8) Value as a percent of net assets.

(9) As of December 31, 2022, 6.5% and 6.6% of the Company's total assets on a cost and fair value basis, respectively, are in non-qualifying assets. Under the 1940 Act, the Company may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company’s total assets.

(10) ETPs are contractual fixed-interest payments due in cash at the maturity date of the applicable debt investment, including upon any prepayment, and are a fixed percentage of the original principal balance of the debt investments unless otherwise noted. Interest will accrue during the life of the debt investment on each ETP and will be recognized as non-cash income until it is actually paid. Therefore, a portion of the incentive fee the Company may pay its Advisor will be based on income that the Company has not yet received in cash.

(11) Debt investment has a PIK feature.

(12) The fair value of the investment was valued using significant unobservable inputs.

(13)	Debt investment is on non-accrual status as of December 31, 2022.
(14)	Entity is organized under the laws of Canada and has a principal place of business in Canada.

See Notes to Consolidated Financial Statements

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for investments owned by investment company.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//946-320/tableOfContent

+ Details

Name:	us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration